D Dimer Testing Global Market Report 2024 - By Trends, Size, Share, Industry Demand, Forecast To 2033

"The new report published by The Business Research Company, titled D Dimer Testing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the d dimer testing market size has grown strongly in recent years. It will grow from $1.38 billion in 2023 to $1.46 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The d dimer testing market size is expected to see steady growth in the next few years. It will grow to $1.77 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Cancer Prevalence Fuels Expansion Of The D-Dimer Testing Market
The increasing prevalence of cancer is expected to propel the growth of the d-dimer testing market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. D-dimer testing is primarily used to help diagnose, monitor, and treat cancer patients and assess the risk of blood clot formation. It monitors thrombotic events in various clinical settings. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in the US in 2022. It is about 1,670 fatalities each day. Therefore, the increasing prevalence of cancer is driving the growth of the d-dimer testing market.

Strategic Partnerships Drive Advancements In The D-Dimer Testing Market
Major companies operating in the d-dimer testing market are adopting a strategic partnership approach to gain exclusive rights to d-dimer testing solutions and gain a competitive edge in the market. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in March 2022, SphingoTec GmbH, a Germany-based biotechnology company, partnered with Rivaara Labs Pvt Ltd., an India-based medical laboratory and healthcare company. Under this partnership, Rivaara gains exclusive rights to market and distribute SphingoTec's point-of-care tests featuring innovative biomarkers in the Indian subcontinent. These biomarkers encompass proenkephalin (penKid) for kidney function assessment, bioactive adrenomedullin (bio-ADM) for endothelial function evaluation, and dipeptidyl peptidase 3 (DPP3) as a biomarker for cardiac depression. These pioneering markers are supplemented by commonly utilized parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

The d dimer testing market covered in this report is segmented -
1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=12341&type=discount

Major companies operating in the d dimer testing market report are Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., Unbound Medicine Inc., AccuBioTech Co Ltd., Response Biomedical Corporation.

Contents of the report:
1. Executive Summary
2. D Dimer Testing Market Report Structure
3. D Dimer Testing Market Trends And Strategies
4. D Dimer Testing Market - Macro Economic Scenario
5. D Dimer Testing Market Size And Growth
…..
27. D Dimer Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.